PMID: 3751505Jun 1, 1986Paper

Neuroleptic malignant syndrome in a patient with acquired immunodeficiency syndrome

Acta Neurologica Scandinavica
W B Bernstein, B Scherokman

Abstract

A patient with acquired immunodeficiency syndrome treated with prochlorperazine and droperidol developed neuroleptic malignant syndrome, characterized by akinetic mutism, resting tremor, cogwheel rigidity, and elevated serum creatine phosphokinase. An identical syndrome reappeared with subsequent administration of haloperidol. Neuroleptic malignant syndrome has not been previously reported in acquired immunodeficiency syndrome.

References

Jan 1, 1984·Clinical Neuropharmacology·R KurlanI Shoulson
Aug 1, 1980·British Journal of Anaesthesia·L J Dupre, P Stieglitz
Jul 1, 1963·The American Journal of Medicine·R A COOPER, E GOLDSTEIN
Nov 1, 1963·Annals of Internal Medicine·B S TYNESJ P UTZ

❮ Previous
Next ❯

Citations

Jun 1, 1992·Digestive Diseases and Sciences·M J SpirtD B Sachar
Nov 1, 1996·The Journal of Emergency Medicine·G R Pesola, C Quinto
Feb 1, 1990·Paraplegia·P L Silbert, J M Davis
Aug 5, 1998·Journal of Clinical Psychopharmacology·S N CaroffM Morrison
Mar 14, 1998·Postgraduate Medical Journal·J L HernándezJ A Riancho
Jul 1, 1989·General Hospital Psychiatry·J R SwensonJ E Dimsdale
Jul 1, 1993·Pediatric Annals·J A Church
Jun 1, 1987·Pediatric Annals·R Heiss
Feb 23, 2010·PLoS Pathogens·Cheryl A StoddartJoseph M McCune
Jun 1, 1988·Drug Intelligence & Clinical Pharmacy·A J WellsM L Crismon
Feb 1, 1990·Paraplegia·A Ohry
Sep 1, 1991·DICP : the Annals of Pharmacotherapy·H E EdelsteinR E McCabe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here